...
首页> 外文期刊>Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry >Lysophosphatidic acid-LPA1 receptor-Rho-Rho kinase-induced up-regulation of Nav1.7 sodium channel mRNA and protein in adrenal chromaffin cells: enhancement of 22Na+ influx, 45Ca2+ influx and catecholamine secretion.
【24h】

Lysophosphatidic acid-LPA1 receptor-Rho-Rho kinase-induced up-regulation of Nav1.7 sodium channel mRNA and protein in adrenal chromaffin cells: enhancement of 22Na+ influx, 45Ca2+ influx and catecholamine secretion.

机译:溶血磷脂酸-LPA1受体-Rho-Rho激酶诱导肾上腺嗜铬细胞中Nav1.7钠通道mRNA和蛋白的上调:增强22Na +流入量,45Ca2 +流入量和儿茶酚胺的分泌。

获取原文
获取原文并翻译 | 示例

摘要

In cultured bovine adrenal chromaffin cells, chronic (> or = 24 h) treatment with lysophosphatidic acid (LPA) augmented veratridine-induced 22Na+ influx via Na(v)1.7 by approximately 22% (EC(50) = 1 nmol/L), without changing nicotine-induced 22Na+ influx via nicotinic receptor-associated channel. LPA enhanced veratridine (but not nicotine)-induced 45Ca2+ influx via voltage-dependent calcium channel and catecholamine secretion. LPA shifted concentration-response curve of veratridine for 22Na+ influx upward, without altering the EC(50) of veratridine. Ptychodiscus brevis toxin-3 allosterically enhanced veratridine-induced 22Na+ influx by twofold in non-treated and LPA-treated cells. Whole-cell patch-clamp analysis showed that peak Na+ current amplitude was greater by 39% in LPA (100 nmol/L for 36 h)-treated cells; however, I-V curve and steady-state inactivation/activation curves were comparable between non-treated and LPA-treated cells. LPA treatment (> or = 24 h) increased cell surface [3H]saxitoxin binding by approximately 28%, without altering the K(d) value; the increase was prevented by cycloheximide, actinomycin D, or Ki16425, dioctylglycerol pyrophosphate 8:0 (two inhibitors of LPA(1) and LPA3 receptors), or botulinum toxin C3 (Rho inhibitor), Y27632 (Rho kinase inhibitor), consistent with LPA(1) receptor expression in adrenal chromaffin cells. LPA raised Nav1.7 mRNA level by approximately 37%. Thus, LPA-LPA(1) receptor-Rho/Rho kinase pathway up-regulated cell surface Nav1.7 and Nav1.7 mRNA levels, enhancing veratridine-induced Ca2+ influx and catecholamine secretion.
机译:在培养的牛肾上腺嗜铬细胞中,用溶血磷脂酸(LPA)进行的长期(>或= 24 h)处理可通过Na(v)1.7增强藜芦啶诱导的22Na +流入,增加约22%(EC(50)= 1 nmol / L),而不通过烟碱样受体相关通道改变烟碱诱导的22Na +流入。 LPA通过电压依赖性钙通道和儿茶酚胺的分泌增强了维拉替丁(而非尼古丁)诱导的45Ca2 +流入。 LPA向上移动了22Na +流入量的维拉替丁的浓度-响应曲线,而没有改变维拉替啶的EC(50)。在未经处理和经LPA处理的细胞中,短缩毕赤酵母毒素3变构增强了藜芦啶诱导的22Na +流入。全细胞膜片钳分析表明,LPA(100 nmol / L持续36 h)处理的细胞的Na +峰值电流幅度增加了39%。然而,未经处理和经LPA处理的细胞的I-V曲线和稳态失活/激活曲线相当。 LPA处理(>或= 24小时)使细胞表面[3H]萨克毒素的结合增加了约28%,而没有改变K(d)值;环己酰亚胺,放线菌素D或Ki16425,焦磷酸二辛基甘油酯8:0(两种LPA(1)和LPA3受体抑制剂)或肉毒毒素C3(Rho抑制剂),Y27632(Rho激酶抑制剂)与LPA一致,可防止这种增加(1)受体在肾上腺嗜铬细胞的表达。 LPA使Nav1.7 mRNA水平提高了约37%。因此,LPA-LPA(1)受体-Rho / Rho激酶途径上调了细胞表面Nav1.7和Nav1.7 mRNA的水平,增强了维拉替丁诱导的Ca2 +内流和儿茶酚胺的分泌。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号